» Articles » PMID: 34280555

Targeting Immune Dysfunction in Aging

Overview
Journal Ageing Res Rev
Specialty Geriatrics
Date 2021 Jul 19
PMID 34280555
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Human aging is a multifactorial phenomenon that affects numerous organ systems and cellular processes, with the immune system being one of the most dysregulated. Immunosenescence, the gradual deterioration of the immune system, and inflammaging, a chronic inflammatory state that persists in the elderly, are among the plethora of immune changes that occur during aging. Almost all populations of immune cells change with age in terms of numbers and/or activity. These alterations are in general highly detrimental, resulting in an increased susceptibility to infections, reduced healing abilities, and altered homeostasis that promote the emergence of age-associated diseases such as cancer, diabetes, and other diseases associated with inflammation. Thanks to recent developments, several strategies have been proposed to target central immunological processes or specific immune subpopulations affected by aging. These therapeutic approaches could soon be applied in the clinic to slow down or even reverse specific age-induced immune changes in order to rejuvenate the immune system and prevent or reduce the impact of various diseases. Due to its systemic nature and interconnection with all the other systems in the body, the immune system is an attractive target for aging intervention because relatively targeted modifications to a small set of cells have the potential to improve the health of multiple organ systems. Therefore, anti-aging immune targeting therapies could represent a potent approach for improving healthspan. Here, we review aging changes in the major components of the immune system, we summarize the current immune-targeting therapeutic approaches in the context of aging and discuss the future directions in the field of immune rejuvenation.

Citing Articles

Age-Related Thymic Involution.

Lins M, Dos Santos Reis M Adv Exp Med Biol. 2025; 1471:285-299.

PMID: 40067592 DOI: 10.1007/978-3-031-77921-3_11.


Delivering miR-23b-3p by small extracellular vesicles to promote cell senescence and aberrant lipid metabolism.

Jin Y, Sun G, Chen B, Feng S, Tang M, Wang H BMC Biol. 2025; 23(1):41.

PMID: 39934790 PMC: 11817603. DOI: 10.1186/s12915-025-02143-9.


Propolis does not significantly modulate immune function in an older population: A preliminary study.

Pu L, Wang Y, Pang W, Wei J, Wu J, Guo C Heliyon. 2025; 10(24):e41056.

PMID: 39759320 PMC: 11699101. DOI: 10.1016/j.heliyon.2024.e41056.


The 3 I's of immunity and aging: immunosenescence, inflammaging, and immune resilience.

Wrona M, Ghosh R, Coll K, Chun C, Yousefzadeh M Front Aging. 2024; 5:1490302.

PMID: 39478807 PMC: 11521913. DOI: 10.3389/fragi.2024.1490302.


Targeting immunosenescence for improved tumor immunotherapy.

Liu Z, Zuo L, Zhou Z, Liu S, Ba Y, Zuo A MedComm (2020). 2024; 5(11):e777.

PMID: 39473905 PMC: 11518697. DOI: 10.1002/mco2.777.